SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pasquini M. Part 1: CIBMTR summary slides, 2005. CIBMTR Newsletter. 2006; 12: 58.
  • 2
    McClellan WM. Epidemiology and risk factors for chronic kidney disease. Med Clin North Am. 2005; 89: 419445.
  • 3
    Chappell ME,Keeling DM,Prentice HG,Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transplant. 1988; 3: 339347.
  • 4
    Delgado J,Cooper N,Thomson K, et al. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006; 12: 7583.
  • 5
    Frisk P,Bratteby LE,Carlson K,Lonnerholm G. Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant. 2002; 29: 129136.
  • 6
    Lawton CA,Cohen EP,Barber-Derus SW, et al. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer. 1991; 67: 27952800.
  • 7
    Leblond V,Sutton L,Jacquiaud C, et al. Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol. 1995; 6: 16611665.
  • 8
    Tarbell NJ,Guinan EC,Chin L,Mauch P,Weinstein HJ. Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radiother Oncol. 1990; 18( suppl 1): 139142.
  • 9
    Van Why SK,Friedman AL,Wei LJ,Hong R. Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant. 1991; 7: 383388.
  • 10
    Gubbins PO,Penzak SR,Polston S,McConnell SA,Anaissie E. Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients. Pharmacotherapy. 2002; 22: 961971.
  • 11
    Miralbell R,Sancho G,Bieri S, et al. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment. Int J Radiat Oncol Biol Phys. 2004; 58: 809816.
  • 12
    Bacigalupo A,Di Giorgio F,Frassoni F, et al. Cyclosporin A serum and blood levels in marrow graft recipients: correlation with administered dose, serum creatinine and graft-versus-host disease. Acta Haematol. 1984; 72: 155162.
  • 13
    Caliskan Y,Besisik SK,Sargin D,Ecder T. Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2006; 38: 141147.
  • 14
    Devine SM,Geller RB,Lin LB, et al. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant. 1997; 3: 2533.
  • 15
    Dieterle A,Gratwohl A,Nizze H, et al. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients. Transplantation. 1990; 49: 10931100.
  • 16
    Furlong T,Storb R,Anasetti C, et al. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. Bone Marrow Transplant. 2000; 26: 985991.
  • 17
    Hows JM,Chipping PM,Fairhead S,Smith J,Baughan A,Gordon-Smith EC. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A. Br J Haematol. 1983; 54: 6978.
  • 18
    Irle C,Deeg HJ,Buckner CD, et al. Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine. Leuk Res. 1985; 9: 12551261.
  • 19
    Nizze H,Mihatsch MJ,Zollinger HU, et al. Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants. Clin Nephrol. 1988; 30: 248260.
  • 20
    Shulman H,Striker G,Deeg HJ,Kennedy M,Storb R,Thomas ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med. 1981; 305: 13921395.
  • 21
    Miralbell R,Bieri S,Mermillod B, et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol. 1996; 14: 579585.
  • 22
    Kal HB,van Kempen-Harteveld ML. Renal dysfunction after total body irradiation: dose-effect relationship. Int J Radiat Oncol Biol Phys. 2006; 65: 12281232.
  • 23
    Kist-van Holthe JE,Goedvolk CA,Brand R, et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol. 2002; 17: 10321037.
  • 24
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 suppl 1 ): S1S266.
  • 25
    [No authors listed] Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol. 1996; 7: 556566.
  • 26
    Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16: 11411154.
  • 27
    Cox D. Regression models and life tables. J R Stat Soc B. 1972; 34: 187220.
  • 28
    Olyaei AJ,de Mattos AM,Bennett WM. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care. 2001; 7: 384389.
  • 29
    Lethbridge-Cejku M,Rose D,Vickerie J.Summary Health Statistics for US Adults: National Health Interview Survey, 2004. Vital Health Statistics, Volume 10, Issue 228. Hyattsville, Md: National Center for Health Statistics; 2006.
  • 30
    Antignac C,Gubler MC,Leverger G,Broyer M,Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int. 1989; 35: 13361344.
  • 31
    Atkinson K,Biggs JC,Hayes J, et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: 3 distinct syndromes. Br J Haematol. 1983; 54: 5967.
  • 32
    Cruz DN,Perazella MA,Mahnensmith RL. Bone marrow transplant nephropathy: a case report and review of the literature. J Am Soc Nephrol. 1997; 8: 166173.
  • 33
    Gomez-Garcia P,Herrera-Arroyo C,Torres-Gomez A, et al. Renal involvement in chronic graft-versus-host disease: a report of 2 cases. Bone Marrow Transplant. 1988; 3: 357362.
  • 34
    Guinan EC,Tarbell NJ,Niemeyer CM,Sallan SE,Weinstein HJ. Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood. 1988; 72: 451455.
  • 35
    Juckett M,Perry EH,Daniels BS,Weisdorf DJ. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant. 1991; 7: 405409.
  • 36
    Glynne P,Powles R,Steele J, et al. Renal dysfunction following autologous bone marrow transplantation in adult patients with acute leukemia. Acta Oncol. 1996; 35: 709712.
  • 37
    Haight AE,Kaste SC,Goloubeva OG,Xiong XP,Bowman LC. Nephrotoxicity of iopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation. Radiology. 2003; 226: 399404.
  • 38
    Kagawa Y,Sawada J-I,Yamada S, et al. Relationship between development of nephrotoxicity and blood concentration of cyclosporine A in bone-marrow transplanted recipients who received the continuous intravenous infusion. Biol Pharm Bull. 2003; 26: 11151119.
  • 39
    Kist-van Holthe JE,Bresters D,Ahmed-Ousenkova YM, et al. Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant. 2005; 36: 605610.
  • 40
    Lawton CA,Cohen EP,Murray KJ, et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant. 1997; 20: 10691074.
  • 41
    Parikh CR,McSweeney PA,Korular D, et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int. 2002; 62: 566573.
  • 42
    Patzer L,Ringelmann F,Kentouche K, et al. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant. 2001; 27: 319327.
  • 43
    Kersting S,Hene RJ,Koomans HA,Verdonck LF. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2007; 13: 11691175.
  • 44
    Hingorani S,Guthrie KA,Schoch G,Weiss NS,McDonald GB. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant. 2007; 39: 223229.
  • 45
    Cohen EP. Radiation nephropathy after bone marrow transplantation. Kidney Int. 2000; 58: 903918.
  • 46
    Stevens LA,Levey AS. Measurement of kidney function. Med Clin North Am. 2005; 89: 457473.
  • 47
    Clark AD,Shetty A,Soutar R. Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma. Blood Rev. 1999; 13: 7990.
  • 48
    Cohen EP. Renal failure after bone-marrow transplantation. Lancet. 2001; 357: 67.
  • 49
    Olyaei AJ,de Mattos AM,Bennett WM. Immunosuppressant-induced nephropathy: pathophysiology, incidence and management. Drug Saf. 1999; 21: 471488.
  • 50
    Deeg HJ,Storb R,Thomas ED, et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood. 1985; 65: 13251334.
  • 51
    Miach PJ. Cyclosporin A in organ transplantation. Med J Aust. 1986; 145: 146150.
  • 52
    Myers BD,Sibley R,Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int. 1988; 33: 590600.
  • 53
    Palestine AG,Austin HA3rd,Balow JE, et al. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med. 1986; 314: 12931298.
  • 54
    Andoh TF,Burdmann EA,Bennett WM. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations. Semin Nephrol. 1997; 17: 3445.